Halozyme Therapeutics Inc (NASDAQ:HALO)

17.45
Delayed Data
As of May 22
 +0.20 / +1.16%
Today’s Change
7.26
Today|||52-Week Range
17.63
+80.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders33.58%
Other institutional29.30%
Individual stakeholders21.93%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account